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The metabolically active endothelium of arterial grafts is reported to slow the atheroscle-
rotic process in the distal coronary territories to which they are grafted with improved
patency. The literature on arterial grafting causing proximal plaque regression is scant. We
report here a case of proximal left anterior descending artery (LAD) plaque regression
following distal arterial grafting with a left internal mammary arterial (LIMA) graft to
LAD. This rarely documented regression resulted in ‘‘stringing’’ of the arterial graft, while
there was a signiﬁcant progression of atherosclerotic disease in the right coronary with
patent venous graft and de novo lesion in circumﬂex territory necessitating percutaneous
coronary intervention, in spite of aggressive medical therapy. The dichotomous progression
of disease in two out of three coronary arterial systems and regression of the proximal
plaque in LAD grafted with LIMA 12 years ago suggests the protective effect of arterial
grafting in reversing the atherosclerotic process.
# 2015 Cardiological Society of India. Published by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. IntroductionCoronary plaque regression is facilitated by aggressive reduc-
tions in LDL and increases in HDL levels which form the
therapeutic goals of statin therapy.1 Coronary artery bypass
grafting (CABG) utilizing arterial grafts has been documented
to retard the atherosclerotic disease progression in the distal
coronary territories. The release of vasoactive molecules from
the endotheliumof the arterial grafts has been proposed as the
probable mechanism behind distal plaque regression.2 How-
ever, the regression of proximal coronary plaques with distal
arterial grafting has been reported only once.3 Here, we report
a case of regression of proximal left anterior descending artery* Corresponding author.
E-mail address: shivnairmd@gmail.com (S.K. Nair).
http://dx.doi.org/10.1016/j.ihj.2015.07.029
0019-4832/# 2015 Cardiological Society of India. Published by Elsevier
(http://creativecommons.org/licenses/by-nc-nd/4.0/).(LAD) plaque 12 years after CABG with a pedicled, in situ, left
internal mammary artery (LIMA) graft.
2. Case reportA 67-year-old hypertensive, dyslipidemicmale presentedwith
recent onset recurrent Canadian Cardiovascular Society (CCS)
class II angina on exertion (AOE) for past 2 months. He had
previously undergone off pump coronary artery grafting
(OPCAB) for critical double vessel disease (diagnosed following
evaluation for AOE-CCS class II) 12 years ago. The preoperative
exercise testing revealed signiﬁcant ST segment depression
with delayed recovery in the anterior, septal, and inferior leadsB.V. This is an open access article under the CC BY-NC-ND license
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Fig. 1 – (a) De novo lesion in LCx (arrow). (b) Successful PCI to LCx lesion-Flow in LAD (arrow) to be noted. (c) Patent LCx prior to
OPCAB with flow limiting lesion in LAD (arrow) 12 years back.
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Fig. 2 – (a) RCA disease prior to OPCAB. (b) Patent RSVG graft with progression to CTO of RCA lesions.
Fig. 3 – Stringed LIMA (arrow).
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) s 4 7 – s 5 0S48and he subsequently underwent coronary angiogram (CAG),
which revealed critical stenosis involving proximal LAD (80%)
and70%and80% tandemstenosis of theproximal andmid right
coronaryartery (RCA), respectively.HeunderwentOPCABwitha
pedicled LIMA to LAD graft and a reversed saphenous vein graft
(RSVG) to posterior descending artery (PDA). He had no other
comorbidities or risk factors for coronary artery disease (CAD)
and was compliant with an optimal drug therapy, which
consisted of aspirin, statins (10mg of Simvastatin initially after
surgerywhichwas subsequently increased to 20mg for the last
8 years and to 40 mg for the last 2 months), ACE inhibitors, and
beta-blockers during the follow-up period. Hewas compliant to
the CAD medical therapy and adhered to a moderate intensity
physical activity regimen,which involved 30–40min ofwalk for
6 days a week. He remained in CCS class I for the past 12 years
with recent onset of recurrent class II effort angina. He had
preserved LV function (no regional wall motion abnormalities,
ejection fraction of 60% with grade I diastolic dysfunction) and
was stage II treadmill test (TMT) positive. CAG done revealed de
novo culprit lesion in proximal circumﬂex territory (LCx) which
was treated by percutaneous coronary intervention (PCI) with
drug eluting stent (DES), with resolution of symptoms (Fig. 1(a)–
(c)). RSVG to PDA was patent with progression of the lesions inRCA to chronic total occlusion (CTO) (Fig. 2(a) and (b)). LIMA
angiography revealed stringing of the arterial graft (Fig. 3).
Interestingly, a regression of the original lesion in the proximal
LAD was noted with re-establishment of an unobstructed
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Fig. 4 – (a) Critically diseased proximal LAD prior to OPCAB (arrow). (b) Plaque regression in LAD (arrow) with increased flow in
the septal arteries. (c) CTCA demonstrating free flowing LIMA graft with no stringing at 9 years follow-up (arrow).
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competitiveﬂowrelatedstringingofLIMAgraft (Fig. 4(a) and (b)).
This observation was further corroborated by a computed
tomography coronary angiography (CTCA) performed 9 years
after the surgery prior to an inguinal hernia repair demonstrat-
ing a patent and free ﬂowing LIMA-LAD graft (Fig. 4(c)). At the
timeof reporting, the patient remains asymptomatic and is free
from inducible ischemia as evidenced by his recent TMT. The
rare ﬁnding of proximal plaque regression following arterial
grafting makes this case unique and worth reporting as it
reinforces the advantages of arterial grafting.
3. DiscussionCoronary atherosclerosis is a dynamic pathology, which
usually follows a progressive course. Plaque progression is a
multicentric process affecting different arterial beds simulta-
neously.4 This process is retarded by the use of aggressive lipid
lowering strategies. The favorable, statin-induced alteration in
the lipid proﬁle retard and at times, regress the coronary
plaques as concluded by recent studies like SATURN.1 The
culprit lesion in LCx explained the recurrence of his symptoms
after 12 years, whichwas treated effectively by PCI-DES. In this
particular case, although the patient had been adhering to
healthy life style modiﬁcations and an aggressive medical
regimen which included high dose statin therapy along with
hypertension control and regular physical activity, the disease
progression in the LCx and RCA coronary beds could not be
modiﬁed, as evidenced from the de novo lesion and CTO
respectively in these territories.
‘‘String Phenomenon’’ or ‘‘disuse atrophy’’ of LIMAwasﬁrst
described by Barner as early as in 1974 and was proposed to be
due to the competitive ﬂow in the native coronary arteries, to
which it is grafted.3,5 The major causes implicated are ﬂow
competition secondary to the grafting of LIMA onto less than
critically occluded coronary territories, harvest injuries,
spasm, and steal phenomenon resulting from a large
undivided proximal branch.6 The classical ‘‘distal stringing’’
seen in this case, could be attributed to the proximal plaque
regression and the consequent ﬂow competition.Arterial grafts, especially LIMA and radial arteries are
known to retard the disease progression in the distal
coronary territories as evidenced from the MASS II trial
and other studies.2,7 Themetabolically active endothelium of
arterial grafts produce nitric oxide, vascular endothelial
growth factor (VEGF) molecules, and endothelial progenitor
cells which may protect the coronary bed to which they are
grafted from atherosclerosis in addition to ensuring their
own patency.8 CABG performed on a critically occluded
coronary system results in both antegrade and retrograde
ﬂow across the vessel lumen. This potentially could subject
the proximal plaque to the beneﬁcial effects of arterial
grafting and subsequently effect plaque regression. The
progression of the disease in other coronary beds (LCx and
RCA), devoid of the protective effects afforded by an arterial
graft probably, resulted in critical lesions in these territories
in spite of adherence to an optimal and aggressive medical
therapy.
The critical nature of the lesion (Fig. 4(a)) was evident on
the CAG at the time of index surgery, in the setting of class II
AOE and the corresponding stress induced ischemia.
Fractional ﬂow reserve (FFR) was relatively a newer, less
popular, and expensive technique lacking well-deﬁned
recommendations for its use 12 years ago. The adequacy
of OPCAB, optimal postoperative medical therapy and the
long term patency of the grafts (LIMA and RSVG) are
supported by the nonrecurrence of angina after OPCAB
and the symptom free follow-up for 12 years. The CTCA
done 3 years ago showing a free ﬂowing LIMA graft without
any evidence of stringing validates the decision to graft LAD
in retrospect.
4. ConclusionsProximal plaque regression after, distal arterial grafting thus,
is a rare but a plausible entity, which should be carefully
investigated, in a larger cohort of patients. The clinical data
presented here favor multiple arterial grafting strategy in
critically stenosed vessels for its potential to modify the
coronary atherosclerotic process.
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